SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Churchill Capital Corp. XI is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on June 4, 2025 and is headquartered in New York, NY.

Churchill Capital Corp XI - Ordinary Shares - Class A

Churchill Capital Corp XI is seeing significant momentum as investors capitalize on institutional positioning from BlueCrest Capital and the expanding narrative surrounding Agility Robotics' commercialization potential. The community is actively debating the company's long-term infrastructure value versus typical SPAC volatility, with many comparing it to successful infrastructure-focused plays like ASTS and RKLB.

Sharplink, Inc. is an institutional-grade Ethereum treasury platform that provides public market investors with exposure to ETH. The platform focuses on Ethereum, which is used in various stablecoin, tokenized real-world asset, and decentralized finance settlement applications. This allows for native yield generation and potential network growth opportunities with ETH. The company is also involved in the online affiliate marketing business. The company was founded in 2019 and is headquartered in Miami, FL.

Sharplink Inc.

SharpLink Gaming Ltd

SharpLink Gaming is trending as investors react to its aggressive Ethereum-focused treasury strategy and recent inclusion in the Russell 2000 and 3000 indexes, which has spurred intense community debate over its long-term viability. While some shareholders view the stock's deep discount to net asset value as a prime accumulation opportunity for the next crypto cycle, others are voicing frustration over sustained downward price pressure and the risks associated with the company's reliance on Ethereum holdings.

Lumen Technologies, Inc. is an investment holding company, which engages in the provision of integrated communications to residential and business customers. It operates through the Business and Mass Markets segments. The Business segment provides products and services under four sales channels to enterprise and commercial customers. The Mass Markets segment focuses on consumer and small business customers. The company was founded in 1930 and is headquartered in Monroe, LA.

Lumen Technologies Inc

Lumen Technologies is experiencing significant volatility driven by the market weighing its pivot toward AI-integrated fiber infrastructure against ongoing balance sheet concerns and structural revenue declines. Community sentiment remains deeply divided, with some investors betting on the company's potential to become a critical AI backbone, while others remain skeptical of the long-term turnaround execution.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is experiencing significant momentum and volatility as investors react to positive FDA briefing documents regarding its mRNA flu vaccine candidate ahead of a key advisory committee vote. The community is actively debating the stock's long-term growth potential through its expanding oncology and rare disease pipeline, while also tracking high short interest that has fueled speculation of a potential short squeeze.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is seeing heightened community engagement driven by anticipation of a potential buyout, as investors weigh the impact of recent product approvals and the company's aggressive pipeline development in the GLP-1 adjunct space. While bullish participants point to valuable clinical assets as prime acquisition targets, others remain focused on navigating volatility and debating the impact of management's confrontational regulatory strategy on future valuation.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is currently a focal point for investors debating whether its aggressive acquisition strategy and high short interest signal an impending rebound or further downside following heavy share dilution. The community is sharply divided, with bulls pointing to the company's expanding backlog and defense partnerships, while vocal critics are focused on insider selling and the stock's poor recent performance.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is trending as investors debate the potential for a buyout following the company's decision to shutter its internal discovery unit and focus on capital-efficient external innovation. The community is actively discussing the stock's future in light of institutional accumulation, ongoing management decisions, and the upcoming data readouts for its HAE drug pipeline.

WorldFinancial

Investors are actively debating the future of World Liberty Financial ($WLFI.X) amid sharp criticism of its performance and vocal community accusations of a potential "rug pull" or grift tied to political branding. While some participants are aggressively calling for a rebound driven by anticipated token burns and supply shocks, others are heavily focused on the significant losses incurred and questioning the project's long-term legitimacy.

SharonAI Holdings, Inc. operates as a holding company that develops and delivers GPU cloud computing and AI solutions. The company was founded on December 30, 2024 and is headquartered in New York, NY.

SharonAI Holdings Inc. - Ordinary Shares - Class A

SharonAI is surging as investors react to a massive five-year, billion-dollar cloud infrastructure contract with ESDS, combined with high-conviction institutional backing from Leopold Aschenbrenners fund. The community is actively discussing the stock's tight float, potential for a short squeeze, and its strategic role as a sovereign AI compute provider in the APAC region.

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.

Abeona Therapeutics Inc

Abeona Therapeutics is trending as investors react to the company's shift from development to commercialization, with community discussion centered on the rollout of ZEVASKYN and anticipation for Q1 earnings. The conversation is heavily focused on potential short squeeze dynamics driven by high short interest, institutional accumulation, and the expectation of revenue acceleration through an expanding network of Qualified Treatment Centers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

DB to Offload India Retail Unit to Kotak Amid Global Hausbank Push

Deutsche Bank to sell its India retail banking business to Kotak, advancing its Global Hausbank strategy and sharpening its focus on higher-growth businesses.

RS Group upgraded to buy at Deutsche Bank on strengthening recovery case

RS Group upgraded to buy at Deutsche Bank on strengthening recovery case...

Deutsche Bank: Tesla's Q2 Vehicle Deliveries Tracking Above Consensus Expectations

Deutsche Bank: Tesla's Q2 Vehicle Deliveries Tracking Above Consensus Expectations

 Tesla could be on track to deliver a stronger than expected second quarter, according to a new research note from Deutsche Bank analyst Edison Yu and his automotive team.

The firm now expects Tesla to...

Here are Deutsche Bank's top investment ideas for the third quarter of 2026

The third quarter is about to kick off after strong first half for stocks, with Deutsche Bank seeing strong performances ahead for a select group of names...

Maersk Lifts Outlook As Wall Street Questions Whether Freight Tailwinds Can Last

Maersk Lifts Outlook As Wall Street Questions Whether Freight Tailwinds Can Last

 A.P. Moller-Maersk shares rose in Copenhagen trading after the world's second-largest container carrier surprised analysts by raising its full-year profit outlook, citing stronger-than-expected...

Comcast is spinning out its media business. Deutsche Bank says it's time to buy the stock

Comcast is planning to spin off NBCUniversal, which makes the stock more attractive to own, according to Deutsche Bank...

NYSE Content Update: Easterly Launches Easterly Snow All Cap Value Fund

NYSE Content Update: Easterly Launches Easterly Snow All Cap Value Fund NYSE Content Update: Easterly Launches Easterly Snow All Cap Value Fund PR Newswire NEW YORK, June 29, 2026 NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, June 29, 2026 /PRNewswire/ -- The New...

Futures Rise As Dip-Buyers Lift Tech Stocks

Futures Rise As Dip-Buyers Lift Tech Stocks

 US equity futures are higher led by Tech as Mag7 leads the group higher and points to a reversal of last week's profit-taking, as traders position for the end of the first half. A shortened week will likely focus on a speech from the Fed's...

Deutsche Bank Cuts PT on Sanofi (SNY) - Here's Why

Deutsche Bank Cuts PT on Sanofi (SNY) - Here's Why...

Deutsche Bank Maintains a Sell Rating on Intuitive Surgical (ISRG), Here's Why

Deutsche Bank Maintains a Sell Rating on Intuitive Surgical (ISRG), Here's Why...

Deutsche Bank AG is a stock corporation company, which engages in the provision of corporate banking, investment services, private banking, and asset management. The company is classified in the Commercial Banks and Capital Markets sector, as per ISS ESG’s sector classification. It operates through the following segments: Corporate Bank, Investment Bank, Private Bank, and Asset Management. The Corporate Bank segment offers cash management, trade finance and lending, foreign exchange, optimization of working capital and liquidity, securing global supply chains, and distribution channels to corporate and commercial clients; correspondent banking, trust and agency, and securities services to financial institutions; and business banking services to small corporate and entrepreneur clients. The Investment Bank segment is involved in origination and advisory businesses as well as fixed-income, currency, sales, and trading, which serves corporate and institutional clients. The Private Bank segment focuses on private bank Germany, private and commercial business international, and wealth management business units, as well as the International private bank, which also caters to commercial clients. The Asset Management segment refers to the investment solutions for individual investors and institutions through the DWS Group GmbH & Co. KGaA brand. The company was founded by Adelbert Delbrück on March 10, 1870 and is headquartered in Frankfurt, Germany.

Deutsche Bank AG - Registered Shares

German Exports To US Fall To 4-Year Low As Trump Tariffs Bite

Equity

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$35.86
Prev Close	$33.86
Open	$36.18
Dividend Yield	2.90%
50-Day Moving Average	$32.58
Beta	1.15
Avg. Volume	2.96M
PE Ratio	10.31

52-Week High	$40.43
52-Week Low	$28.12
Market Capitalization	$67.47B
EPS (Annual)	$3.56
Price to Book	0.87
Revenue Per Employee	$802,783.45

Feed

News

Sentiment

Earnings

Fundamentals

Info

DBDeutsche Bank AG - Registered Shares

Latest DB News